Age and founder effect of S0D1 A4V mutation causing ALS

Neurology

Volumn 72, Issue 19, 2009, Pages 1634-1639

  Saeed, M ^a   Yang, Y ^a   Deng, H X ^a   Hung, W Y ^a   Siddique, N ^a   Dellefave, L ^a   Gellera, C ^c   Andersen, P M ^d   Siddique, T ^a,b  

^a Department of Neurology and Clinical Neurosciences ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CODON; FAMILIAL DISEASE; FOUNDER EFFECT; GENE MUTATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NORTH AMERICA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 67049108824     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000343509.76828.2a     Document Type: Article

References (18)

1. Tandan R, Bradley WG. Amyotrophic lateral sclerosis, part 1: clinical features, pathology, and ethical issues in management. Ann Neurol 1985;18:271-280.
2. Tandan R, Bradley WG. Amyotrophic lateral sclerosis, part 2: etiopathogenesis. Ann Neurol 1985;18:419-431.
3. Bobowick AR, Brody JA. Epidemiology of motor neuron diseases [review]. N Engl J Med 1973;288:1047-1055.
4. Nelson LM. Epidemiology of ALS. Clin Neurosci 1995;3: 327-331.
5. Siddique T, Figlewicz DA, Pericak-Vance MA, et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 1991;324:1381-1384.
6. Siddique T, Deng HX. Genetics of amyotrophic lateral sclerosis. Hum Mol Genet 1996;5:1465-1470.
7. Kabashi E, Valdmanis PN, Dion P, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008;40:572-574.
8. Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008;319:1668-1672.
9. Van Deerlin VM, Leverenz JB, Bekris LM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 2008;7:409-416.
10. Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu, Zn superoxide dismutase. Neurology 1997;48:55-57.
11. Deng HX, Shi Y, Furukawa Y, et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mi- tochondria. Proc Natl Acad Sci USA 2006;103:7142-7147.
12. Radunovic A, Leigh PN. ALSO Database: database of SOD1 (and other) gene mutations in ALS on the Internet: European FALS Group and ALSOD Consortium. Amyotroph Lateral Scler Other Motor Neuron Disord 1999;1:45-49.
13. Deng HX, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 1993;261:1047-1051.
14. Barrett JC, Fry B, Mailer J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformat-ics 2005;21:263-265.
15. Reeve JP, Rannala B. DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics 2002;18: 894-895.
16. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001;29:229-232.
17. Rosen DR. A shared chromosome-21 haplotype among amyotrophic lateral sclerosis families with the A4V SOD1 mutation. Clin Genet 2004;66:247-250.
18. Al-Chalabi A, Andersen PM, Chioza B, et al. Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum Mol Genet 1998:7:2045-2050.